The article discusses Denmark as a global connection. Denmark has a history of generating successful pharmaceutical companies, conducting clinical trials, and creating biotechnology companies. The Danish government launched a globalization strategy in 2006 in response to the strength of its basic research. The focus of the strategy is aimed at increasing funding for research and development (R&D) to advance science and innovation. Topics include the growth of Denmark's Ph.D. scholarship programs, which includes many foreign born students, the trilateral partnership between corporate, clinical, and academic institutions, and support for basic and applied research from Denmark's private sector.